4.3 Article

'Cough-triggered' tuberculosis screening among adults with diabetes in Tanzania

Journal

DIABETIC MEDICINE
Volume 31, Issue 5, Pages 600-605

Publisher

WILEY
DOI: 10.1111/dme.12348

Keywords

-

Ask authors/readers for more resources

Aims Diabetes increases the risk of tuberculosis and the prevalence of diabetes is rising in tuberculosis-endemic regions such as sub-Saharan Africa. Resource-appropriate strategies for tuberculosis case finding among African adults with diabetes are needed. The aims of this study were to determine prevalence of tuberculosis and evaluate one screening strategy among adult Tanzanians with diabetes. Methods In this prospective cohort study, we evaluated a 'cough-triggered' strategy for tuberculosis case finding among adults with diabetes at our zonal hospital in Tanzania. All adults with diabetes and cough underwent further tuberculosis symptom assessment, and those with productive cough had sputum collected for microscopy and Mycobacterium tuberculosis culture. Results Between September 2011 and March 2012, 700 adults with diabetes attended our hospital. A total of 693 were enrolled, 121/693 (17.5%) had cough and 32/693 (4.6%) had at least two of the classic symptoms of tuberculosis. Of note, 87/121 (71.9%) of patients with cough could not produce sputum spontaneously. Nine patients were diagnosed with tuberculosis for a prevalence of 1299/100000 (1.3%), sevenfold greater than the national average. Conclusions Tuberculosis is common among Tanzanian adults with diabetes, but tuberculosis case finding is challenging because of the high prevalence of non-productive cough. This low-cost, 'cough-triggered' tuberculosis case-finding strategy may serve as a reasonable first step for improving tuberculosis screening among adults with diabetes in sub-Saharan Africa.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Linkage to Care Intervention to Improve Post-Hospital Outcomes Among Children with Sickle Cell Disease in Tanzania: A Pilot Study

Duncan K. Hau, Emmanuela E. Ambrose, Luke R. Smart, Neema M. Kayange, Robert N. Peck

Summary: A pilot study was conducted in Tanzania to evaluate the effectiveness of a linkage to care intervention with social workers for children with sickle cell disease, resulting in a significant decrease in 12-month post-hospital mortality compared to a historical cohort.

JOURNAL OF PEDIATRICS (2021)

Article Clinical Neurology

Pediatric Hydrocephalus in Northwest Tanzania: A Descriptive Cross-Sectional Study of Clinical Characteristics and Early Surgical Outcomes from the Bugando Medical Centre

Camilla G. Aukrust, Karishma Parikh, Luke R. Smart, Ibrahimu Mdala, Heidi E. Fjeld, James Lubuulwa, Antonia Msafiri Makene, Roger Hartl, Andrea Sylvia Winkler

Summary: This study examined the demographics, clinical characteristics, surgical treatment, and early clinical outcomes of pediatric patients with hydrocephalus in Tanzania. The findings highlight the importance of targeted investments in clinical services to improve access to care and surgical capacity, as well as reduce the burden of pediatric hydrocephalus in sub-Saharan Africa.

WORLD NEUROSURGERY (2022)

Review Peripheral Vascular Disease

Emerging Viral Infections, Hypertension, and Cardiovascular Disease in Sub-Saharan Africa: A Narrative Review

Lily D. Yan, Sarah S. Matuja, Kevin J. Pain, Margaret L. McNairy, Anthony O. Etyang, Robert N. Peck

Summary: This narrative review examines the interaction between hypertension, cardiovascular disease (CVD), and emerging viral infections in Sub-Saharan Africa (SSA). The findings indicate an association between COVID-19 and preexisting hypertension or CVD, but research gaps remain for other emerging viral infections in SSA.

HYPERTENSION (2022)

Article Hematology

Stroke Prevention with Hydroxyurea Enabled through Research and Education (SPHERE): a Phase 2 primary stroke prevention trial in sub-Saharan Africa

Luke R. R. Smart, Emmanuela E. E. Ambrose, Georgina Balyorugulu, Primrose Songoro, Idd Shabani, Protas Komba, Mwesige Charles, Thad A. A. Howard, Kathryn E. E. McElhinney, Sara M. M. O'Hara, Jodie Odame, Maria Nakafeero, Janet Adams, Susan E. E. Stuber, Adam Lane, Teresa S. S. Latham, Abel N. N. Makubi, Russell E. E. Ware

Summary: SPHERE is a clinical trial for sickle cell anemia in Tanzania, which incorporates TCD screening to predict stroke risk and provide relevant treatment. The study findings show a high prevalence of elevated baseline TCD velocities and splenomegaly among participants, and SPHERE aims to determine the benefits of hydroxyurea in stroke prevention and expand access to hydroxyurea treatment in Tanzania.

ACTA HAEMATOLOGICA (2023)

Meeting Abstract Hematology

Hydroxyurea with Dose-Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Tanzania: Primary Results of the Sphere Trial

Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro, Mwesige Charles, Adam Lane, Susan E. Stuber, Abel Nkono Makubi, Russell E. Ware, Luke R. Smart

BLOOD (2022)

Article Hematology

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa

Peter Olupot-Olupot, George Tomlinson, Thomas N. Williams, Leon Tshilolo, Brigida Santos, Luke R. Smart, Kathryn McElhinney, Thad A. Howard, Banu Aygun, Susan E. Stuber, Adam Lane, Teresa S. Latham, Russell E. Ware

Summary: The REACH study provides hydroxyurea at maximum tolerated dose for children with sickle cell anemia in sub-Saharan Africa, and it not only reduces SCA-related clinical events but also decreases malaria incidence by around 50%. The study analyzed the associations between hydroxyurea and lower malaria rates, through recording infections in clinical sites across Angola, Democratic Republic of Congo, Kenya, and Uganda. The results showed that ANC and splenomegaly were significant factors associated with malaria risk, and hydroxyurea treatment at MTD led to lower malaria incidence through incompletely defined mechanisms.

BLOOD (2023)

Article Hematology

Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial

Emmanuela E. Ambrose, Teresa S. Latham, Primrose Songoro, Mwesige Charles, Adam C. Lane, Susan E. Stuber, Abel N. Makubi, Russell E. Ware, Luke R. Smart

Summary: This study aimed to estimate stroke risk in children with sickle cell anaemia in Tanzania and determine the efficacy of hydroxyurea to decrease and prevent stroke. The results showed that hydroxyurea at the maximum tolerated dose significantly lowered transcranial Doppler velocities and reduced the risk of stroke, supporting wider access to hydroxyurea for patients with sickle cell anaemia in sub-Saharan Africa.

LANCET HAEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings

Luke R. Smart, Mwesige Charles, Kathryn E. McElhinney, Min Dong, Alexandra Power-Hays, Thad Howard, Alexander A. Vinks, Emmanuela E. Ambrose, Russell E. Ware

Summary: Hydroxyurea is an effective treatment for sickle cell anemia. Pharmacokinetic-guided dosing can predict a personalized optimal dose, but requires complex analytical techniques. This study successfully simplified the hydroxyurea pharmacokinetic analysis and demonstrated its feasibility in low-resource settings.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Article Medicine, Research & Experimental

Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease

Luke R. Smart, Catherine I. Segbefia, Teresa S. Latham, Susan E. Stuber, Kwesi N. Amissah-Arthur, Klenam Dzefi-Tettey, Adam C. Lane, Yvonne A. Dei-Adomakoh, Russell E. Ware

Summary: This study aims to evaluate the safety of hydroxyurea treatment and its effects on clinical and laboratory parameters in individuals with HbSC disease, and to provide measurable outcome measures for future phase III clinical trials.

TRIALS (2023)

Article Pharmacology & Pharmacy

Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia

Alexandra Power-Hays, Min Dong, Nieko Punt, Tomoyuki Mizuno, Luke R. Smart, Alexander A. Vinks, Russell E. Ware

Summary: Hydroxyurea treatment is effective for children with sickle cell anemia, but determining the optimal dose is challenging. HdxSim, an online clinical decision support tool, provides accurate dosing predictions and improves outcomes.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Letter Cardiac & Cardiovascular Systems

Translating Ethics into Practice: Providing LongTerm Cardiometabolic and Cardiovascular Disease Care for Research Participants in Africa

Cody Cichowitz, Godfrey Kisigo, Grace Ruselu, Bahati Wajanga, Bernard Desderius, Anthony O. Etyang, Saidi Kapiga, Robert Peck

GLOBAL HEART (2023)

Meeting Abstract Pediatrics

Linkage to Care Intervention to Improve Post-hospital Outcomes Among Children with Sickle Cell Anemia in Tanzania: A Pilot Study

Duncan K. Hau, Emmanuela E. Ambrose, Luke R. Smart, Neema M. Kayange, Robert N. Peck

PEDIATRICS (2022)

Meeting Abstract Hematology

FT-4202, an allosteric activator of pyruvate kinase-R, demonstrates proof of mechanism and proof of concept after multiple daily doses in a phase 1 study of patients with sickle cell disease

R. Clark Brown, Kimberly Cruz, Theodosia A. Kalfa, Frans A. Kuypers, Santosh L. Saraf, Jeremie H. Estepp, Luke R. Smart, Punam Malik, Mark Lerman, Renae Mayer, Maria D. Ribadeneira, Sanjeev Forsyth, Patricia Schroeder, Eric Wu, Patrick Kelly, Marilyn J. Telen

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Meeting Abstract Pediatrics

Bedside Expedited Testing for Anemia in Tanzania: the BETA Study

Luke Smart, Emmanuela Eusebio Ambrose, Mwesige Charles, Marina Perez-Plazola, Idd Shabani, Protas Komba, Primrose Songoro, Erika Tyburski, Wilbur Lam, Russell E. Ware, Patrick T. McGann

PEDIATRICS (2021)

Meeting Abstract Pediatrics

Extremely High Birth Prevalence of Sickle Cell Disease in Rural Tanzania

Luke Eastburg, Andrew Peckham, Esther Kawira, Bwire Chirang, David Adler, Brian Dee Akungo, Luke Smart, Emmanuela Eusebio Ambrose

PEDIATRICS (2021)

No Data Available